A Study of RGX-202-01 (Ompenaclid) as Combination Therapy in RAS Mutant Advanced Colorectal Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Robert Wasserman, MD
CMO
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Arizona Oncology Associates, Pc - Hal
Prescott Valley, Arizona, United States
- Arizona Oncology Associates, Pc - Hop E
Tucson, Arizona, United States
- Cedars-Sinai Medical Center
Los Angeles, California, United States
- Sharp Healthcare
San Diego, California, United States
- Sansum Clinic
Santa Barbara, California, United States
- Ucla Department of Medicine
Santa Monica, California, United States
- Medical Oncology Hematology Consultants, Pa
Newark, Delaware, United States
- Oncology Hematology West P.C. Dba Nebraska Cancer Specialists
Omaha, Nebraska, United States
- Dartmouth
Lebanon, New Hampshire, United States
- Memorial Sloan Kettering Cancer Center
New York, New York, United States
- University of North Carolina Chapel Hill
Chapel Hill, North Carolina, United States
- Northwest Cancer Specialists, P.C.
Portland, Oregon, United States
- Thomas Jefferson
Philadelphia, Pennsylvania, United States
- Prisma Health Cancer Institute
Greenville, South Carolina, United States
- Tennessee Oncology
Nashville, Tennessee, United States
- Texas Oncology, P.A
McAllen, Texas, United States
- Texas Oncology, P.A
Tyler, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 5 Jun 2018
- Primary completion
- 31 Mar 2025
- Completion
- 31 Mar 2025
- Last update posted
- 3 Apr 2025
- Registered enrollment
- 89
- Registry id
- NCT03597581
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.